Announcements
Aspen Pharmacare Australia announces a new partnership with Eli Lilly Australia for Zyprexa®
Australian News, Announcements
Aspen Pharmacare Australia Pty Ltd (Aspen) is pleased to announce a new partnership with Eli Lilly Australia (Lilly) for Zyprexa® (olanzapine), a market leading medication for schizophrenia and bipolar disorder
Formal Agreement Reached for $900 Million Sale of Pharmaceuticals Division to Aspen Pharmacare
Australian News, Announcements
On 16 August 2010, Sigma announced that it had agreed in principle to sell its Pharmaceuticals Division to the Aspen Pharmacare Holdings Limited group of companies for A$900 million.
Aspen to distribute Merck products
Australian News, Announcements
Effective immediately, Aspen is taking over the sales, distribution and marketing of a portfolio of dermatology products from Merck, with estimated annual sales of $50 million.
Stephen Saad, CEO of Aspen Holdings, comments on Sigma purchase
Australian News, New Zealand News, Announcements
An interview of Stephen Saad, CEO of Aspen Holdings.
Aspen Announcement to JSE
Australian News, Announcements
Announcement regarding the acquisition of the pharmaceutical business of Sigma Pharmaceuticals Limited by Aspen.
Aspen and GSK Agree On Series Of Strategic Transactions
Australian News, Announcements
Aspen, Africa's largest pharmaceutical manufacturer, has announced that it has agreed to multiple, strategic, inter-dependent transactions with a leading multinational pharmaceutical group, GlaxoSmithKline.
Aspen form alliance with Actavis
Aspen Australia have signed a license agreement with Actavis, taking on the sales, marketing and distribution of two products, Neotigason and Rapilysin.
